Testing EOC237 for advanced solid tumors that need new options
Part of Cancer clinical trials.
This early-stage trial tests EOC237 in people with advanced solid tumors when standard treatments are no longer working. It’s meant to see whether the treatment can be given safely and start to show if it may help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor where standard curative or palliative treatments don’t work anymore (or don’t exist)
- Your expected survival is at least 3 months
- Your day-to-day function is good (ECOG 0–1, meaning you’re fully active or limited but able to care for yourself)
- You have good blood counts and organ function based on lab tests
- You are not pregnant or breastfeeding, and you have no recent/uncontrolled serious illnesses that could interfere
- You have not had a severe allergic reaction to a drug before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called ES014 for people with advanced solid tumors that can't be removed or have spread. It's an early trial to see if ES014 is safe and helps fight certain cancers.
This trial tests a new drug called QLC5508, given in combination with other treatments, for people with advanced solid tumors that have stopped responding to standard therapy or who haven't had treatment yet. The goal is to see if the combination can shrink tumors or slow their growth.
This trial tests an experimental drug called ONC-783 for people with advanced pancreatic, ovarian, colorectal, or breast cancer. The goal is to see if the drug is safe, how it works in the body, and whether it can help shrink tumors.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
This trial tests a new drug called JSKN027 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.
This trial tests a new combination treatment (HC010) for people with advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.